Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
09/2003
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345606A2 Texaphyrin coordination compounds and uses thereof
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003EP1259512B1 Pteridine compounds for the treatment of psoriasis
09/24/2003EP1252163B1 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
09/24/2003EP1196419B1 Potassium channel blocking agents
09/24/2003EP1150953B1 Indole derivatives and their use as mcp-1 receptor antagonists
09/24/2003EP1051415B1 Benzamide derivatives as vasopressin antagonists
09/24/2003EP1021444B1 3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES
09/24/2003EP0920430B1 Purine derivatives and their use as anti-coagulants
09/24/2003CN1444585A Crystalline therapeutic agent
09/24/2003CN1444566A Imidazolyl derivatives
09/24/2003CN1443765A New compound, its synthetic method and use
09/24/2003CN1443764A New condensed tricyclonucleoside compound containing acyclovir fragment and its preparation method
09/24/2003CN1122033C Triazolopurine derivatives, medicinal composition containing the derivatives
09/24/2003CN1122032C Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
09/23/2003US6624187 Long wave length absorbing bacteriochlorin alkyl ether analogs
09/23/2003US6624175 4-heterocyclic substituted quinoline derivative treats disorderes associated with pathogenic neurokinin-3 receptor, such as anxiety, depression, schizophrenia, obesity, chronic pulmonary obstructive disorder or pain
09/23/2003US6624173 Pharmaceutical compositions for treating and/or preventing CNS disorders
09/23/2003US6624167 Compounds that are capable of affecting nicotinic cholinergic receptors. A wide variety of conditions and disorders, and particularly conditions and disorders associated with dysfunction of the central and autonomic nervous systems can
09/23/2003CA2093631C Pyrroloazepine derivative
09/18/2003WO2003077215A2 Fluorescent nitrogenous base and nucleosides incorporating same
09/18/2003WO2003076442A1 Purine derivatives as kinase inhibitors
09/18/2003WO2003076441A1 Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
09/18/2003WO2003076440A1 Condensed heterocyclic compounds as calcitonin agonists
09/18/2003WO2003076427A1 Quinazoline compounds useful in therapy
09/18/2003WO2003076426A2 Pyridinyloxy derivatives as 5-ht receptor ligands
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076412A1 Novel hairpin polyamide
09/18/2003WO2003048122A3 Inhibitors of cytosolic phospholipase a2
09/18/2003WO2003037897A3 Use of 7h-pyrrolo[2,3-d]pyrimidine derivatives in the treatment of solid tumor diseases
09/18/2003WO2003022848A3 Process for the preparation of diketopyrrolopyrroles
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003US20030176723 Modifying chemoselectivity during oxidation of nitrogen compounds
09/18/2003US20030176702 N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
09/18/2003US20030176701 Di-or triaza-spiro [4,5] decane derivatives
09/18/2003US20030176700 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones
09/18/2003US20030176698 Such as (R)-2-cyclopentyl-7,8-dihydro-8-(4-picolyl)-4-(n-propyl)-1H-imidazo(2,1 -i)purin-5(4H)-one d-tartaric acid, which has glucose concentration-dependent insulin secretion promoting action/hypoglycemic activity; antidiabetic agents
09/18/2003US20030176696 Preparing pyrazolopyrimidinone derivatives for the treatment of impotence
09/18/2003US20030176691 Asymmetric synthesis of piperazic acid and derivatives thereof
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176450 Pyrazolopyrimidines
09/18/2003US20030176449 For therapy and prophylaxis of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders
09/18/2003US20030176442 Administering cGMP PDE5 inhibitor for therapy of diabetic ulcers
09/18/2003US20030176437 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
09/18/2003US20030176436 For therapy and prophylaxis of bacterial infections, or their use as antiseptics, sterilizants, or disinfectants
09/18/2003US20030176435 Binding to the NMDA receptor glycine site have utility for the amelioration of pain and particularly for amelioration of neuropathic pain
09/18/2003US20030176434 Compounds and methods for promoting smoking cessation
09/18/2003US20030176430 For therapy and prophylaxis of Tachykinin-mediated diseases
09/18/2003US20030176427 Fungicidal formulation
09/18/2003US20030176422 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
09/18/2003US20030176416 For therapy of disease, disorder or condition is responsive to modulation of cholinergic receptors and/or monoamine receptors
09/18/2003US20030176413 Polycyclic guanine derivative phosphodiesterase V inhibitors
09/18/2003CA2479016A1 Quinazoline compounds useful in therapy
09/18/2003CA2475254A1 Pyridinyloxy derivatives as 5-ht receptor ligands
09/17/2003EP1344779A1 Azolo-pyrimidines
09/17/2003EP1344771A1 2-alkoxy-phenylsulphonic acid derivatives as intermediates for herbicidal sulphonylamino(thio)carbonyl compounds
09/17/2003EP1344768A2 Synthesis of substituted pyrazolopyrimidines
09/17/2003EP1343788A1 Imidazo-triazine derivatives as ligands for gaba receptors
09/17/2003EP1343787A1 6-phenyl-pyrazolopyrimidines
09/17/2003EP1343785A2 Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
09/17/2003EP1343768A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
09/17/2003EP1343506A1 Pharmaceutical formulation containing pyrazolo 4,3-d]pyrimidines and antithrombotic agents, calcium-antagonists, prostaglandins or prostaglandin derivatives
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1183317B1 Process for the preparation of herbicidal derivatives
09/17/2003EP1131324B1 Method for the demethoxycarbonylation of porphyrinic compounds such as pheophorbides
09/17/2003EP1123296B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
09/17/2003EP1049697B1 Triazolo-pyridazine derivatives as ligands for gaba receptors
09/17/2003EP0909184B1 Targeted drug delivery using sulfonamide derivatives
09/17/2003EP0804439B1 Beta, beta '-dihydroxy meso-substituted chlorins, isobacteriochlorins, bacteriochlorins, and methods for making the same from beta ,beta '-unsubstituted tetrapyrrolic macrocycles
09/17/2003EP0702683B1 06-substituted guanine derivatives, a process for their preparation and their use in treating tumour cells
09/17/2003EP0588858B1 IMIDAZO 2,1-b] 3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE
09/17/2003CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function
09/17/2003CN1443174A Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
09/17/2003CN1443167A Azacyclic compounds for use in treatment of 5-serotonin related diseases
09/17/2003CN1443162A New combination of serotonin agonist (5HT2) and antagonist (5HT6) as pharmaceutical formulation
09/17/2003CN1442402A Method of selectively synthesizing triethylene diamine
09/17/2003CN1121400C Synthesis of triethylene diamide and diethylenediamine by using zeolite catalyst modified by silicon contained compound
09/16/2003US6620929 1,3-Dipolar cycloadditions to polypyrrolic macrocycles
09/16/2003CA2215695C .beta.-sheet mimetics and use thereof as protease inhibitors
09/16/2003CA2078759C Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
09/16/2003CA2046429C Imide derivatives, and their production and use
09/12/2003WO2003074530A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
09/12/2003WO2003074526A2 Method and system for separation and purification of at least one narcotic alkaloid using reverse phase preparative chromatography
09/12/2003WO2003074525A1 Nitrogen-containing heterocyclic compound
09/12/2003WO2003034987A3 Androgen receptor modulators and methods of use thereof
09/12/2003WO2002060871A3 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/12/2003WO2002040486A3 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS
09/12/2003CA2477739A1 Method and system for separation and purification of at least one narcotic alkaloid using reverse phase preparative chromatography
09/12/2003CA2477721A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
09/12/2003CA2476757A1 Nitrogen-containing heterocyclic compound
09/11/2003US20030171610 Catalyst asymmetric desymmetrization of prochiral compounds
09/11/2003US20030171584 6-Substituted pyrido-pyrimidines
09/11/2003US20030171418 Pyranoindazoles and their use for the treatment of glaucoma
09/11/2003US20030171381 Therapy for Parkinson's disease; antidepressants; antiepileptic agents
09/11/2003US20030171366 Having antibacterial activity against Gram-positive and Gram-negative bacteria
09/11/2003US20030171365 Inhibitors of the interleukin-1beta conversion enzyme; useful in treatment of inflammatory, auto-immune and neurodegenerative diseases
09/11/2003US20030171364 Phosphodiesterase inhibitor compounds; therapeutic activity as anti-inflammatory and anti-allergic medicinal products, and in the treatment of various respiratory diseases such as asthma
09/11/2003US20030171361 Treatment of impotence, sexual dysfunction in female, stable, unstable and variant angina, hypertension, pulmonary hypertension, congestive heart failure, atherosclerosis
1 ... 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 ... 573